KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to $20.5 million.

  • Jazz Pharmaceuticals' Cash from Financing Activities fell 104.39% to -$10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$957.1 million, marking a year-over-year decrease of 1238.31%. This contributed to the annual value of $20.5 million for FY2024, which is 106.72% up from last year.
  • As of FY2024, Jazz Pharmaceuticals' Cash from Financing Activities stood at $20.5 million, which was up 106.72% from -$305.3 million recorded in FY2023.
  • Jazz Pharmaceuticals' 5-year Cash from Financing Activities high stood at $4.0 billion for FY2021, and its period low was -$529.5 million during FY2022.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$305.3 million (2023), whereas its average is -$271.4 million.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Cash from Financing Activities soared by 651.89% in 2021 and then slumped by 113.34% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Cash from Financing Activities (Yearly) stood at $528.1 million in 2020, then skyrocketed by 651.89% to $4.0 billion in 2021, then crashed by 113.34% to -$529.5 million in 2022, then surged by 42.35% to -$305.3 million in 2023, then spiked by 106.72% to $20.5 million in 2024.